Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4636493
Max Phase: Preclinical
Molecular Formula: C51H74N12O12S2
Molecular Weight: 1111.36
Molecule Type: Unknown
Associated Items:
ID: ALA4636493
Max Phase: Preclinical
Molecular Formula: C51H74N12O12S2
Molecular Weight: 1111.36
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCN(CC)C(=S)SCc1ccc(NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCNC(=N)N)cc1
Standard InChI: InChI=1S/C51H74N12O12S2/c1-5-63(6-2)51(76)77-28-32-9-15-33(16-10-32)56-44(70)37(22-29(3)4)57-47(73)41(26-65)61-46(72)39(24-31-13-19-35(68)20-14-31)58-45(71)38(23-30-11-17-34(67)18-12-30)59-48(74)42(27-66)62-49(75)40(25-64)60-43(69)36(52)8-7-21-55-50(53)54/h9-20,29,36-42,64-68H,5-8,21-28,52H2,1-4H3,(H,56,70)(H,57,73)(H,58,71)(H,59,74)(H,60,69)(H,61,72)(H,62,75)(H4,53,54,55)/t36-,37-,38-,39-,40-,41-,42-/m0/s1
Standard InChI Key: VVXUHOJVEMBOAL-FVMQRRFMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1111.36 | Molecular Weight (Monoisotopic): 1110.4991 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Bakthavatsalam S, Wiangnak P, George DJ, Zhang T, Franz KJ.. (2020) Dithiocarbamate prodrugs activated by prostate specific antigen to target prostate cancer., 30 (11): [PMID:32253061] [10.1016/j.bmcl.2020.127148] |
Source(1):